Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Summit trims size of offering:

This article was originally published in Clinica

Executive Summary

Summit Technology is to scale back its public offering to 3.5 million shares, priced at $16.00. The Waltham, Massachusetts-based company, whose share price soared to more than $29.00 last month, following the FDA advisory panel recommendation for its LASIK vision correction laser, is presently trading at around the offer price. The company plans to use the funds to commercialise its LADAR radar eye tracking and narrow beam lens shaping technology. Initially it planned to offer four million shares.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079245

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel